AI Image
Meet this year’s Endpoints 11
Endpoints News • • business
Key Points:
- The 2026 Endpoints 11 awards highlight emerging biotech startups, reflecting a shift in the industry driven by fundamentals rather than pandemic-era narratives, with renewed funding from public and private markets.
- The biotech sector faces new uncertainties due to changing power dynamics influenced by AI, China's growing role, and innovative companies poised to become major players.
- The selected 11 startups focus on diverse areas including gene therapy, CAR-T, oncology, cardiology, longevity, AI, robotics, and novel drug development methods.
- Notable companies on the list include China-based Anew Labs, Azalea Therapeutics combining gene editing with CAR-T, and Medra developing self-driving labs to transform scientific research.
- The winners were announced at a gala in Boston, with a replay available on September 28, and while not all startups will succeed, the selection process emphasizes promising ideas and strong teams.
